Skip to search formSkip to main contentSkip to account menu

PR 39

Known as: PR-39, PR-39 proline-arginine-rich peptide, PR39 proline-arginine-rich peptide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Two antimicrobial peptides, cecropin P1 (CP1), with a C-terminal carboxyl group, and PR-39, with an amidated, C-terminus, are… 
2007
2007
PR-39, a proline-arginine-rich angiogenic response peptide, has been implicated in myocardial ischemic reperfusion injury. The… 
2007
2007
PR‐39 is a cathelicidin with antimicrobial properties, which acts as a suppressor of inflammation and exerts a number of… 
2004
2004
Two experiments were conducted to evaluate developmental gene expression of antimicrobial peptide PR-39 and effect of zinc oxide… 
2004
2004
The lethal effects occurring in neonatal (< 24-h old) BALB/c mice after challenge with E. coli lipopolysaccharide (LPS) were… 
2001
2001
PR‐39 is proline‐rich peptide produced at sites of tissue injury. While the functional properties of this peptide have not been… 
Highly Cited
1999
Highly Cited
1999
SummaryPR-39 is an endogenous proline-rich antimicrobial peptide which induces the synthesis of syndecan-1, a transmembrane… 
1999
1999
ABSTRACT Cathelicidins constitute a family of mammalian antimicrobial peptides that are synthesized in the bone marrow as… 
Highly Cited
1994
Highly Cited
1994
Neutrophil nonoxidative defense mechanisms include several low molecular weight antimicrobial peptides. We have isolated a…